Rigel Pharmaceuticals | 10-Q:季度報表
Rigel Pharmaceuticals | 8-K:銳傑公佈2024年第一季度財務業績並提供業務最新情況
Rigel Pharmaceuticals | 8-K:重大事件
Rigel Pharmaceuticals | ARS:年度報告
Rigel Pharmaceuticals | DEFA14A:其他
Rigel Pharmaceuticals | DEF 14A:股東委託書決議
Rigel Pharmaceuticals | PRE 14A:並購重組委托聲明
Rigel Pharmaceuticals | 4:持股變動聲明-高管 Rojkjaer Lisa
Rigel Pharmaceuticals | 3:首次持股聲明-高管 Rojkjaer Lisa
Rigel Pharmaceuticals | 8-K:銳佳公佈2023年第四季度和全年財務業績並提供業務最新情況
Rigel Pharmaceuticals | 10-K:年度報表
Rigel Pharmaceuticals | 4:持股變動聲明-高管 Schorno Dean L
Rigel Pharmaceuticals | 4:持股變動聲明-高管 Santos David A
Rigel Pharmaceuticals | 4:持股變動聲明-高管 RODRIGUEZ RAUL R
Rigel Pharmaceuticals | 4:持股變動聲明-高管 Furey Raymond J.
Rigel Pharmaceuticals | 8-K:重大事件
Rigel Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(9.81%),Steven Boyd(9.81%)
Rigel Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.13%)
Rigel Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Morgan Stanley(8.3%),Morgan Stanley Capital Services LLC(8.1%)
Rigel Pharmaceuticals | 4:持股變動聲明-高管 Santos David A
暫無數據